MedXCell SA is pleased to announce the publication of its BiorespX paper in the International Journal of Pharmaceutics
Montreux, Switzerland | April 4, 2023 – MedXCell SA, a European venture builder that specializes in cell therapy for major diseases such as cancer, autoimmune,